P

PvP Biologics, Inc.

2 employees

PvP Biologics is developing an oral enzyme for the treatment of celiac disease.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

Therapeutics

Health Care

2016

P

PvP Biologics, Inc. raised undisclosed on January 1, 2018

Investors: Sahsen Ventures, LLC